| 1. |
第十三屆全國人民代表大會常務委員會第七次會議. 國務院關于財政醫療衛生資金分配和使用情況的報告. 2018.
|
| 2. |
European Network for Health Technology Assessment. HTA core model 3.0. 2016.
|
| 3. |
Chen Y, Zhao K, Liu G, et al. Health technology assessment to inform decision making in China: progress, challenges, and sustainability. BMJ, 2023, 381: e068910.
|
| 4. |
World Health Organization. Health technology assessment of medical devices. 2011.
|
| 5. |
National institute for Health and Care Excellence. Guide to the processes of technology appraisal. 2018.
|
| 6. |
National institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. 2013.
|
| 7. |
European Network for Health Technology Assessment. Assessment element tables for HTA core model application for pharmaceuticals 3.0. 2016.
|
| 8. |
European Network for Health Technology Assessment. Assessment element tables for HTA core model application for medical and surgical interventions 3.0. 2016.
|
| 9. |
European Network for Health Technology Assessment. Assessment element tables for HTA core model application for screening technologies 3.0. 2016.
|
| 10. |
European Network for Health Technology Assessment. Assessment element tables for HTA core model application for diagnostic technologies 3.0. 2016.
|
| 11. |
徐佩佩, 李汶睿, 曾力楠, 等. 國內外衛生技術評估方法學指南的系統評價. 中國藥房, 2020, 31(12): 1500-1505.
|
| 12. |
National institute for Health and Care Excellence. Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma. 2020.
|
| 13. |
吳雪, 徐思敏, 戴澤琦, 等. 國內外衛生技術評估機構的概況性綜述. 中國實驗方劑學雜志, 2022, 28(20): 178-185.
|
| 14. |
World Health Organization. HTA country/area profile. 2021.
|
| 15. |
Sampietro CL, Martin J. Hospital-based health technology assessment. 2016.
|
| 16. |
Sampietro CL, Lach K, Cicchetti A, et al. The AdHopHTA handbook. 2015.
|
| 17. |
Health Intervention and Technology Assessment Program. Health technology assessment process guidelines. 2012.
|
| 18. |
Taylor R. Guidelines for authors of CADTH health technology assessment reports. 2003.
|
| 19. |
Institut für Qualit?t und Wirtschaftlichkeit im Gesundheitswesen. General method (version 7). 2022.
|
| 20. |
Oortwijn W, Broos P, Vondeling H, et al. Mapping of health technology assessment in selected countries. Int J Technol Assess Health Care, 2013, 29(4): 424-434.
|
| 21. |
Stretch L, Amend E. A guide to health technology assessment in the Palliser health region. 2005.
|
| 22. |
Radaelli G, Lettieri E, Masella C, et al. Implementation of EUnetHTA core Model? in Lombardia: the VTS framework. Int J Technol Assess Health Care, 2014, 30(1): 105-112.
|
| 23. |
O'Rourke B, Oortwijn W, Schuller T, et al. The new definition of health technology assessment: a milestone in international collaboration. Int J Technol Assess Health Care, 2020, 36(3): 187-190.
|
| 24. |
戴澤琦, 景城陽, 吳雪, 等. 國內外藥品臨床綜合評價指標體系研究的系統評價. 中國循證醫學雜志, 2023, 23(7): 776-782.
|
| 25. |
盧靜雅, 沈建通, 趙齊園, 等. 醫院衛生技術評估的流程與方法新進展. 中國循證醫學雜志, 2019, 19(11): 1367-1372.
|
| 26. |
International Network of Agencies for Health Technology Assessment. A checklist for HTA reports (Version 4.0). 2007.
|
| 27. |
Chugh Y, Bahuguna P, Sohail A, et al. Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India. Appl Health Econ Health Policy, 2023, 21(1): 11-22.
|
| 28. |
Av?ar TS, Yang X, Lorgelly P. How is the societal perspective defined in health technology assessment. guidelines from around the globe. Pharmacoeconomics, 2023, 41(2): 123-138.
|
| 29. |
Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ, 1986, 5(1): 1-30.
|
| 30. |
J?nsson B. Ten arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ, 2009, 10(4): 357-359.
|
| 31. |
Arntsen KA, Blount LG, Dickerson BJ, et al. Patient-centered health technology assessment: a perspective on engagement in health technology assessment by three patient organizations and a health technology assessment body. Int J Technol Assess Health Care, 2022, 38(1): e76.
|